Keurig Dr Pepper Reports Strong Q3 2021 Results and Raises Net Sales Guidance for the Year
Keurig Dr Pepper (NASDAQ: KDP) reported robust Q3 2021 results, with net sales increasing 7.6% to $3.25 billion and adjusted diluted EPS rising 12.8% to $0.44. The company raised its sales growth forecast for 2021 to 7-8% and reaffirmed EPS growth guidance of 13-15%. The strong performance was driven by double-digit growth in Beverage Concentrates and Latin America Beverages. Despite challenges from inflation and higher operating expenses, KDP's management leverage ratio improved, lowering to 3.2x.
- Net sales increased 7.6% to $3.25 billion in Q3 2021.
- Adjusted diluted EPS rose 12.8% to $0.44.
- Beverage Concentrates and Latin America Beverages showed double-digit growth.
- Raised 2021 sales growth forecast to 7-8% from 6-7%.
- Management leverage ratio improved to 3.2x.
- Inflation in input costs and logistics pressures.
- Increased operating expenses due to high consumer demand.
- Higher marketing investment impacted operating margins.
BURLINGTON, Mass. and FRISCO, Texas, Oct. 28, 2021 /PRNewswire/ -- Keurig Dr Pepper Inc. (NASDAQ: KDP) today reported strong and balanced financial results for the third quarter ended September 30, 2021 and raised its guidance for net sales growth, which is now expected in the range of
Reported GAAP Basis | Adjusted Basis1 | |||
Q3 | YTD 2021 | Q3 | YTD 2021 | |
Net Sales % vs Prior Year % vs Prior Year – Constant Currency % vs YTD 2019 – Constant Currency | ||||
Diluted EPS % vs Prior Year % vs YTD 2019 |
Commenting on the announcement, Chairman and CEO Bob Gamgort stated, "In the quarter, we continued to effectively manage through macro challenges to deliver strong and balanced results. We are now entering the final quarter of our three-year, post-merger period with excellent top-line momentum and are on track to deliver or exceed our original merger commitments. Our outlook for the business remains strong, as we look forward to our next chapter of transformation and growth."
Third Quarter Consolidated Results
Net sales for the third quarter of 2021 increased
KDP in-market performance in the Liquid Refreshment Beverages (LRB) category remained strong in the quarter, with retail dollar consumption2 advancing
In coffee, retail consumption of single-serve pods manufactured by KDP in IRi tracked channels increased
GAAP operating income increased
Adjusted operating income grew
GAAP net income grew
Adjusted net income advanced
Free cash flow totaled
1 | Adjusted financial metrics used in this release are non-GAAP. See reconciliations of GAAP results to Adjusted results in the accompanying tables. | |
2 | Retail consumption data based on Keurig Dr Pepper's custom IRi category definitions for the 13-week period ending 9/26/2021. | |
3 | CSDs refer to "Carbonated Soft Drinks". |
Third Quarter Segment Results
Coffee Systems
Net sales for the third quarter of 2021 advanced
The volume/mix increase of
GAAP operating income increased
Adjusted operating income increased
Packaged Beverages
Net sales for the third quarter of 2021 increased
GAAP operating income increased
Adjusted operating income advanced
Beverage Concentrates
Net sales for the third quarter of 2021 increased
Total shipment volume versus year-ago decreased
GAAP operating income increased
Adjusted operating income increased
Latin America Beverages
Net sales for the third quarter of 2021 increased
GAAP operating income increased
Adjusted operating income increased
Outlook for 2021
The Company raised its guidance for constant currency net sales growth to the range of
KDP Investor Contact:
Steve Alexander
T: 972-673-6769 / steve.alexander@kdrp.com
KDP Media Contact:
Katie Gilroy
T: 781-418-3345 / katie.gilroy@kdrp.com
About Keurig Dr Pepper
Keurig Dr Pepper (KDP) is a leading beverage company in North America, with annual revenue in excess of
FORWARD LOOKING STATEMENTS
Certain statements contained herein are "forward-looking statements" within the meaning of applicable securities laws and regulations. These forward-looking statements can generally be identified by the use of words such as "outlook," "guidance," "anticipate," "expect," "believe," "could," "estimate," "feel," "forecast," "intend," "may," "plan," "potential," "project," "should," "target," "will," "would," and similar words. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. These statements are based on the current expectations of our management, are not predictions of actual performance, and actual results may differ materially.
Forward-looking statements are subject to a number of risks and uncertainties, including the impact of the global COVID-19 pandemic and the factors disclosed in our Annual Report on Form 10-K and subsequent filings with the SEC. We are under no obligation to update, modify or withdraw any forward-looking statements, except as required by applicable law.
NON-GAAP FINANCIAL MEASURES
This release includes certain non-GAAP financial measures including Adjusted operating income, Adjusted net income, Adjusted diluted EPS and free cash flow, which differ from results using U.S. Generally Accepted Accounting Principles (GAAP). These non-GAAP financial measures should be considered as supplements to the GAAP reported measures, should not be considered replacements for, or superior to, the GAAP measures and may not be comparable to similarly named measures used by other companies. Non-GAAP financial measures typically exclude certain charges, including one-time costs that are not expected to occur routinely in future periods. The Company uses non-GAAP financial measures internally to focus management on performance excluding these special charges to gauge our business operating performance. Management believes this information is helpful to investors because it increases transparency and assists investors in understanding the underlying performance of the Company and in the analysis of ongoing operating trends. Additionally, management believes that non-GAAP financial measures are frequently used by analysts and investors in their evaluation of companies, and their continued inclusion provides consistency in financial reporting and enables analysts and investors to perform meaningful comparisons of past, present and future operating results. The most directly comparable GAAP financial measures and reconciliations to non-GAAP financial measures are set forth in the appendix to this release and included in the Company's filings with the SEC.
To the extent that the Company provides guidance, it does so only on a non-GAAP basis and does not provide reconciliations of such forward-looking non-GAAP measures to GAAP due to the inability to predict the amount and timing of impacts outside of the Company's control on certain items, such as non-cash gains or losses resulting from mark-to-market adjustments of derivative instruments, among others.
KEURIG DR PEPPER INC. | |||||||||||||||
Third Quarter | First Nine Months | ||||||||||||||
(in millions, except per share data) | 2021 | 2020 | 2021 | 2020 | |||||||||||
Net sales | $ | 3,250 | $ | 3,020 | $ | 9,292 | $ | 8,497 | |||||||
Cost of sales | 1,415 | 1,316 | 4,087 | 3,779 | |||||||||||
Gross profit | 1,835 | 1,704 | 5,205 | 4,718 | |||||||||||
Selling, general and administrative expenses | 1,040 | 949 | 3,040 | 2,978 | |||||||||||
Other operating expense (income), net | — | 2 | (4) | (40) | |||||||||||
Income from operations | 795 | 753 | 2,169 | 1,780 | |||||||||||
Interest expense | 116 | 148 | 381 | 458 | |||||||||||
Loss on early extinguishment of debt | — | — | 105 | 4 | |||||||||||
Impairment of investments and note receivable | — | 16 | — | 102 | |||||||||||
Other expense (income), net | 1 | 5 | (6) | 21 | |||||||||||
Income before provision for income taxes | 678 | 584 | 1,689 | 1,195 | |||||||||||
Provision for income taxes | 149 | 141 | 387 | 298 | |||||||||||
Net income including non-controlling interest | 529 | 443 | 1,302 | 897 | |||||||||||
Less: Net income (loss) attributable to non-controlling interest | (1) | — | (1) | — | |||||||||||
Net income attributable to KDP | $ | 530 | $ | 443 | $ | 1,303 | $ | 897 | |||||||
Earnings per common share: | |||||||||||||||
Basic | $ | 0.37 | $ | 0.31 | $ | 0.92 | $ | 0.64 | |||||||
Diluted | 0.37 | 0.31 | 0.91 | 0.63 | |||||||||||
Weighted average common shares outstanding: | |||||||||||||||
Basic | 1,417.6 | 1,407.3 | 1,414.9 | 1,407.2 | |||||||||||
Diluted | 1,428.5 | 1,422.9 | 1,427.5 | 1,421.5 |
KEURIG DR PEPPER INC. | |||||||
September 30, | December 31, | ||||||
(in millions, except share and per share data) | 2021 | 2020 | |||||
Assets | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 200 | $ | 240 | |||
Restricted cash and restricted cash equivalents | 3 | 15 | |||||
Trade accounts receivable, net | 1,138 | 1,048 | |||||
Inventories | 972 | 762 | |||||
Prepaid expenses and other current assets | 490 | 323 | |||||
Total current assets | 2,803 | 2,388 | |||||
Property, plant and equipment, net | 2,425 | 2,212 | |||||
Investments in unconsolidated affiliates | 85 | 88 | |||||
Goodwill | 20,193 | 20,184 | |||||
Other intangible assets, net | 23,883 | 23,968 | |||||
Other non-current assets | 901 | 894 | |||||
Deferred tax assets | 40 | 45 | |||||
Total assets | $ | 50,330 | $ | 49,779 | |||
Liabilities and Stockholders' Equity | |||||||
Current liabilities: | |||||||
Accounts payable | $ | 4,072 | $ | 3,740 | |||
Accrued expenses | 1,121 | 1,040 | |||||
Structured payables | 142 | 153 | |||||
Short-term borrowings and current portion of long-term obligations | 998 | 2,345 | |||||
Other current liabilities | 462 | 416 | |||||
Total current liabilities | 6,795 | 7,694 | |||||
Long-term obligations | 11,727 | 11,143 | |||||
Deferred tax liabilities | 5,940 | 5,993 | |||||
Other non-current liabilities | 1,463 | 1,119 | |||||
Total liabilities | 25,925 | 25,949 | |||||
Commitments and contingencies | |||||||
Stockholders' equity: | |||||||
Preferred stock, | — | — | |||||
Common stock, | 14 | 14 | |||||
Additional paid-in capital | 21,764 | 21,677 | |||||
Retained earnings | 2,621 | 2,061 | |||||
Accumulated other comprehensive loss | 6 | 77 | |||||
Total stockholders' equity | 24,405 | 23,829 | |||||
Non-controlling interest | — | 1 | |||||
Total equity | 24,405 | 23,830 | |||||
Total liabilities and stockholders' equity | $ | 50,330 | $ | 49,779 |
KEURIG DR PEPPER INC. | |||||||
First Nine Months | |||||||
(in millions) | 2021 | 2020 | |||||
Operating activities: | |||||||
Net income attributable to KDP | $ | 1,303 | $ | 897 | |||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||
Depreciation expense | 304 | 272 | |||||
Amortization of intangibles | 101 | 100 | |||||
Other amortization expense | 118 | 118 | |||||
Provision for sales returns | 48 | 36 | |||||
Deferred income taxes | (21) | (27) | |||||
Employee stock-based compensation expense | 68 | 62 | |||||
Loss on early extinguishment of debt | 105 | 4 | |||||
Gain on disposal of property, plant and equipment | (5) | (39) | |||||
Unrealized loss on foreign currency | 1 | 14 | |||||
Unrealized (gain) loss on derivatives | (94) | 47 | |||||
Equity in loss of unconsolidated affiliates | 2 | 19 | |||||
Impairment on investments and note receivable of unconsolidated affiliate | — | 102 | |||||
Other, net | 10 | 50 | |||||
Changes in assets and liabilities: | |||||||
Trade accounts receivable | (126) | (1) | |||||
Inventories | (210) | (175) | |||||
Income taxes receivable and payables, net | (11) | (118) | |||||
Other current and non-current assets | (181) | (387) | |||||
Accounts payable and accrued expenses | 536 | 500 | |||||
Other current and non-current liabilities | (15) | 192 | |||||
Net change in operating assets and liabilities | (7) | 11 | |||||
Net cash provided by operating activities | 1,933 | 1,666 | |||||
Investing activities: | |||||||
Purchases of property, plant and equipment | (325) | (356) | |||||
Proceeds from sales of property, plant and equipment | 18 | 203 | |||||
Purchases of intangibles | (31) | (26) | |||||
Issuance of related party note receivable | (17) | (6) | |||||
Investments in unconsolidated affiliates | — | (4) | |||||
Other, net | 5 | 7 | |||||
Net cash used in investing activities | (350) | (182) | |||||
Financing activities: | |||||||
Proceeds from issuance of Notes | 2,150 | 1,500 | |||||
Repayments of Notes | (3,595) | (250) | |||||
Proceeds from issuance of commercial paper | 4,756 | 6,843 | |||||
Repayments of commercial paper | (3,758) | (7,754) | |||||
Proceeds from KDP Revolver | — | 1,850 | |||||
Repayments of KDP Revolver | — | (1,850) | |||||
Proceeds from sale of stock by JAB | — | 29 | |||||
Repayments of 2019 KDP Term Loan | (425) | (880) | |||||
Proceeds from structured payables | 112 | 128 | |||||
Repayments of structured payables | (123) | (290) | |||||
Cash dividends paid | (687) | (635) | |||||
Proceeds from issuance of common stock | 140 | — | |||||
Tax withholdings related to net share settlements | (125) | — | |||||
Payments on finance leases | (40) | (35) | |||||
Other, net | (35) | (22) | |||||
Net cash used in financing activities | (1,630) | (1,366) | |||||
Cash, cash equivalents, restricted cash, and restricted cash equivalents: | |||||||
Net change from operating, investing and financing activities | (47) | 118 | |||||
Effect of exchange rate changes | (5) | (11) | |||||
Beginning balance | 255 | 111 | |||||
Ending balance | $ | 203 | $ | 218 |
KEURIG DR PEPPER INC. | |||||||||||||||
Third Quarter | First Nine Months | ||||||||||||||
(in millions) | 2021 | 2020 | 2021 | 2020 | |||||||||||
Net Sales | |||||||||||||||
Coffee Systems | $ | 1,155 | $ | 1,097 | $ | 3,398 | $ | 3,113 | |||||||
Packaged Beverages | 1,547 | 1,447 | 4,352 | 4,056 | |||||||||||
Beverage Concentrates | 392 | 352 | 1,095 | 967 | |||||||||||
Latin America Beverages | 156 | 124 | 447 | 361 | |||||||||||
Total net sales | $ | 3,250 | $ | 3,020 | $ | 9,292 | $ | 8,497 | |||||||
Income from Operations | |||||||||||||||
Coffee Systems | $ | 334 | $ | 320 | $ | 992 | $ | 882 | |||||||
Packaged Beverages | 288 | 260 | 721 | 657 | |||||||||||
Beverage Concentrates | 286 | 262 | 778 | 679 | |||||||||||
Latin America Beverages | 37 | 25 | 95 | 73 | |||||||||||
Unallocated corporate costs | (150) | (114) | (417) | (511) | |||||||||||
Total income from operations | $ | 795 | $ | 753 | $ | 2,169 | $ | 1,780 |
KEURIG DR PEPPER INC.
RECONCILIATION OF CERTAIN NON-GAAP INFORMATION
(UNAUDITED)
The company reports its financial results in accordance with U.S. GAAP. However, management believes that certain non-GAAP financial measures that reflect the way management evaluates the business may provide investors with additional information regarding the company's results, trends and ongoing performance on a comparable basis.
For the third quarter of 2021 and 2020, we define our Adjusted non-GAAP financial measures as certain financial statement captions and metrics adjusted for certain items affecting comparability. The items affecting comparability are defined below.
Specifically, investors should consider the following with respect to our financial results:
Adjusted: Defined as certain financial statement captions and metrics adjusted for certain items affecting comparability.
Items affecting comparability: Defined as certain items that are excluded for comparison to prior year periods, adjusted for the tax impact as applicable. Tax impact is determined based upon an approximate rate for each item. For each period, management adjusts for (i) the unrealized mark-to-market impact of derivative instruments not designated as hedges in accordance with U.S. GAAP and do not have an offsetting risk reflected within the financial results; (ii) the amortization associated with definite-lived intangible assets; (iii) the amortization of the deferred financing costs associated with the DPS Merger; (iv) the amortization of the fair value adjustment of the senior unsecured notes obtained as a result of the DPS Merger; (v) stock compensation expense and the associated windfall tax benefit attributable to the matching awards made to employees who made an initial investment in KDP; (vi) non-cash changes in deferred tax liabilities related to goodwill and other intangible assets as a result of tax rate or apportionment changes; and (vii) other certain items that are excluded for comparison purposes to prior year periods.
For the third quarter and first nine months of 2021, the other certain items excluded for comparison purposes include (i) restructuring and integration expenses related to significant business combinations; (ii) productivity expenses; (iii) costs related to significant non-routine legal matters; (iv) the loss on early extinguishment of debt related to the redemption of debt; (v) incremental costs to our operations related to risks associated with the COVID-19 pandemic; and (vi) gains from insurance recoveries related to the February 2019 organized malware attack on our business operation networks in the Coffee Systems segment.
For the third quarter and first nine months of 2020, the other certain items excluded for comparison purposes include (i) restructuring and integration expenses related to significant business combinations; (ii) productivity expenses; (iii) transaction costs for significant business combinations (completed or abandoned) excluding the DPS Merger; (iv) costs related to significant non-routine legal matters; (v) the loss on early extinguishment of debt related to the redemption of debt, (vi) incremental costs to our operations related to risks associated with the COVID-19 pandemic and (vii) impairment recognized on our equity method investments with Bedford and LifeFuels.
Incremental costs to our operations related to risks associated with the COVID-19 pandemic include incremental expenses incurred to either maintain the health and safety of our front-line employees or temporarily increase compensation to such employees to ensure essential operations continue during the pandemic. We believe removing these costs reflects how management views our business results on a consistent basis.
For the third quarter and first nine months of 2021 and 2020, the supplemental financial data set forth below includes reconciliations of Adjusted income from operations, Adjusted net income and Adjusted diluted EPS to the applicable financial measure presented in the unaudited condensed consolidated financial statement for the same period.
Reconciliations for these items are provided in the tables below.
KEURIG DR PEPPER INC. RECONCILIATION OF CERTAIN REPORTED ITEMS TO CERTAIN NON-GAAP ADJUSTED ITEMS For the Third Quarter of 2021 (Unaudited, in millions, except per share data) | |||||||||||||||||||||
Cost of sales | Gross profit | Gross margin | Selling, general and administrative expenses | Income from operations | Operating margin | ||||||||||||||||
Reported | $ | 1,415 | $ | 1,835 | 56.5 | % | $ | 1,040 | $ | 795 | 24.5 | % | |||||||||
Items Affecting Comparability: | |||||||||||||||||||||
Mark to market | 27 | (27) | (18) | (9) | |||||||||||||||||
Amortization of intangibles | — | — | (34) | 34 | |||||||||||||||||
Stock compensation | — | — | (3) | 3 | |||||||||||||||||
Restructuring and integration costs | — | — | (53) | 53 | |||||||||||||||||
Productivity | (21) | 21 | (23) | 44 | |||||||||||||||||
Nonroutine legal matters | — | — | (7) | 7 | |||||||||||||||||
COVID-19 | (3) | 3 | (1) | 4 | |||||||||||||||||
Transaction Costs | — | — | (1) | 1 | |||||||||||||||||
Malware incident | — | — | 1 | (1) | |||||||||||||||||
Adjusted | $ | 1,418 | $ | 1,832 | 56.4 | % | $ | 901 | $ | 931 | 28.6 | % |
Interest expense | Income before provision for income taxes | Provision for income taxes | Effective tax rate | Net income attributable to KDP | Diluted earnings per share | |||||||||||||||||
Reported | $ | 116 | $ | 678 | $ | 149 | 22.0 | % | $ | 530 | $ | 0.37 | ||||||||||
Items Affecting Comparability: | ||||||||||||||||||||||
Mark to market | — | (9) | (3) | (6) | — | |||||||||||||||||
Amortization of intangibles | — | 34 | 9 | 25 | 0.02 | |||||||||||||||||
Amortization of deferred financing costs | (2) | 2 | 2 | — | — | |||||||||||||||||
Amortization of fair value debt adjustment | (4) | 4 | 1 | 3 | — | |||||||||||||||||
Stock compensation | — | 3 | — | 3 | — | |||||||||||||||||
Restructuring and integration costs | — | 53 | 13 | 40 | 0.03 | |||||||||||||||||
Productivity | — | 44 | 11 | 33 | 0.02 | |||||||||||||||||
Loss on early extinguishment of debt | — | — | (1) | 1 | — | |||||||||||||||||
Nonroutine legal matters | — | 7 | 2 | 5 | — | |||||||||||||||||
COVID-19 | — | 4 | 1 | 3 | — | |||||||||||||||||
Transaction Costs | — | 1 | — | 1 | — | |||||||||||||||||
Malware incident | — | (1) | (1) | — | — | |||||||||||||||||
Change in deferred tax liabilities related to goodwill and other | — | — | 7 | (7) | — | |||||||||||||||||
Adjusted | $ | 110 | $ | 820 | $ | 190 | 23.2 | % | $ | 631 | $ | 0.44 | ||||||||||
Diluted earnings per common share may not foot due to rounding. |
KEURIG DR PEPPER INC. RECONCILIATION OF CERTAIN REPORTED ITEMS TO CERTAIN NON-GAAP ADJUSTED ITEMS For the Third Quarter of 2020 (Unaudited, in millions, except per share data) | |||||||||||||||||||||
Cost of sales | Gross profit | Gross margin | Selling, general and administrative expenses | Income from operations | Operating margin | ||||||||||||||||
Reported | $ | 1,316 | $ | 1,704 | 56.4 | % | $ | 949 | $ | 753 | 24.9 | % | |||||||||
Items Affecting Comparability: | |||||||||||||||||||||
Mark to market | 46 | (46) | (1) | (45) | |||||||||||||||||
Amortization of intangibles | — | — | (34) | 34 | |||||||||||||||||
Stock compensation | — | — | (6) | 6 | |||||||||||||||||
Restructuring and integration costs | — | — | (39) | 39 | |||||||||||||||||
Productivity | (10) | 10 | (20) | 30 | |||||||||||||||||
Nonroutine legal matters | — | — | (8) | 8 | |||||||||||||||||
COVID-19 | (19) | 19 | (30) | 49 | |||||||||||||||||
Adjusted | $ | 1,333 | $ | 1,687 | 55.9 | % | $ | 811 | $ | 874 | 28.9 | % |
Interest expense | Impairment of investments and note receivable | Income before provision for income taxes | Provision for income taxes | Effective tax rate | Net income attributable to KDP | Diluted earnings per share | ||||||||||||||||||||
Reported | $ | 148 | $ | 16 | $ | 584 | $ | 141 | 24.1 | % | $ | 443 | $ | 0.31 | ||||||||||||
Items Affecting Comparability: | ||||||||||||||||||||||||||
Mark to market | (1) | — | (44) | (13) | (31) | (0.02) | ||||||||||||||||||||
Amortization of intangibles | — | — | 34 | 9 | 25 | 0.02 | ||||||||||||||||||||
Amortization of deferred financing costs | (2) | — | 2 | 1 | 1 | — | ||||||||||||||||||||
Amortization of fair value debt adjustment | (6) | — | 6 | 1 | 5 | — | ||||||||||||||||||||
Stock compensation | — | — | 6 | 1 | 5 | — | ||||||||||||||||||||
Restructuring and integration costs | — | — | 39 | 8 | 31 | 0.02 | ||||||||||||||||||||
Productivity | — | — | 30 | 8 | 22 | 0.02 | ||||||||||||||||||||
Impairment on Investment | — | (16) | 16 | 4 | 12 | 0.01 | ||||||||||||||||||||
Nonroutine legal matters | — | — | 8 | 1 | 7 | — | ||||||||||||||||||||
COVID-19 | — | — | 49 | 12 | 37 | 0.03 | ||||||||||||||||||||
Adjusted | $ | 139 | $ | — | $ | 730 | $ | 173 | 23.7 | % | $ | 557 | $ | 0.39 | ||||||||||||
Diluted earnings per common share may not foot due to rounding. |
KEURIG DR PEPPER INC. RECONCILIATION OF CERTAIN REPORTED ITEMS TO CERTAIN NON-GAAP ADJUSTED ITEMS For the First Nine Months of 2021 (Unaudited, in millions, except per share data) | |||||||||||||||||||||
Cost of sales | Gross profit | Gross margin | Selling, general and administrative expenses | Income from operations | Operating margin | ||||||||||||||||
Reported | $ | 4,087 | $ | 5,205 | 56.0 | % | $ | 3,040 | $ | 2,169 | 23.3 | % | |||||||||
Items Affecting Comparability: | |||||||||||||||||||||
Mark to market | 53 | (53) | 32 | (85) | |||||||||||||||||
Amortization of intangibles | — | — | (101) | 101 | |||||||||||||||||
Stock compensation | — | — | (14) | 14 | |||||||||||||||||
Restructuring and integration costs | — | — | (145) | 145 | |||||||||||||||||
Productivity | (43) | 43 | (72) | 115 | |||||||||||||||||
Nonroutine legal matters | — | — | (23) | 23 | |||||||||||||||||
COVID-19 | (22) | 22 | (9) | 31 | |||||||||||||||||
Transaction costs | — | — | (1) | 1 | |||||||||||||||||
Malware incident | — | — | 3 | (3) | |||||||||||||||||
Adjusted | $ | 4,075 | $ | 5,217 | 56.1 | % | $ | 2,710 | $ | 2,511 | 27.0 | % |
Interest expense | Loss on early extinguishment of debt | Income before provision for income taxes | Provision for income taxes | Effective tax rate | Net income attributable to KDP | Diluted earnings per share | ||||||||||||||||||||
Reported | $ | 381 | $ | 105 | $ | 1,689 | $ | 387 | 22.9 | % | $ | 1,303 | $ | 0.91 | ||||||||||||
Items Affecting Comparability: | ||||||||||||||||||||||||||
Mark to market | 7 | — | (92) | (23) | (69) | (0.05) | ||||||||||||||||||||
Amortization of intangibles | — | — | 101 | 26 | 75 | 0.05 | ||||||||||||||||||||
Amortization of deferred financing costs | (6) | — | 6 | 2 | 4 | — | ||||||||||||||||||||
Amortization of fair value debt adjustment | (14) | — | 14 | 3 | 11 | 0.01 | ||||||||||||||||||||
Stock compensation | — | — | 14 | 14 | — | — | ||||||||||||||||||||
Restructuring and integration costs | — | — | 145 | 35 | 110 | 0.08 | ||||||||||||||||||||
Productivity | — | — | 115 | 29 | 86 | 0.06 | ||||||||||||||||||||
Loss on early extinguishment of debt | — | (105) | 105 | 24 | 81 | 0.06 | ||||||||||||||||||||
Nonroutine legal matters | — | — | 23 | 5 | 18 | 0.01 | ||||||||||||||||||||
COVID-19 | — | — | 31 | 8 | 23 | 0.02 | ||||||||||||||||||||
Transaction costs | — | — | 1 | — | 1 | — | ||||||||||||||||||||
Malware incident | — | — | (3) | (1) | (2) | — | ||||||||||||||||||||
Change in deferred tax liabilities related to goodwill and other intangible | — | — | — | 1 | (1) | — | ||||||||||||||||||||
Adjusted | $ | 368 | $ | — | $ | 2,149 | $ | 510 | 23.7 | % | $ | 1,640 | $ | 1.15 | ||||||||||||
Diluted earnings per common share may not foot due to rounding. |
KEURIG DR PEPPER INC. RECONCILIATION OF CERTAIN REPORTED ITEMS TO CERTAIN NON-GAAP ADJUSTED ITEMS For the First Nine Months of 2020 (Unaudited, in millions, except per share data) | |||||||||||||||||||||
Cost of sales | Gross profit | Gross margin | Selling, general and administrative expenses | Income from operations | Operating margin | ||||||||||||||||
Reported | $ | 3,779 | $ | 4,718 | 55.5 | % | $ | 2,978 | $ | 1,780 | 20.9 | % | |||||||||
Items Affecting Comparability: | |||||||||||||||||||||
Mark to market | 2 | (2) | (28) | 26 | |||||||||||||||||
Amortization of intangibles | — | — | (100) | 100 | |||||||||||||||||
Stock compensation | — | — | (21) | 21 | |||||||||||||||||
Restructuring and integration costs | — | — | (143) | 143 | |||||||||||||||||
Productivity | (28) | 28 | (75) | 103 | |||||||||||||||||
Nonroutine legal matters | — | — | (43) | 43 | |||||||||||||||||
COVID-19 | (38) | 38 | (79) | 117 | |||||||||||||||||
Adjusted | $ | 3,715 | $ | 4,782 | 56.3 | % | $ | 2,489 | $ | 2,333 | 27.5 | % |
Interest expense | Loss on early extinguishment of debt | Impairment of investment and note receivable | Income before provision for income taxes | Provision for income taxes | Effective tax rate | Net income | Diluted earnings per share | |||||||||||||||||||||||
Reported | $ | 458 | $ | 4 | $ | 102 | $ | 1,195 | $ | 298 | 24.9 | % | $ | 897 | $ | 0.63 | ||||||||||||||
Items Affecting Comparability: | ||||||||||||||||||||||||||||||
Mark to market | (28) | — | — | 54 | 13 | 41 | 0.03 | |||||||||||||||||||||||
Amortization of intangibles | — | — | — | 100 | 27 | 73 | 0.05 | |||||||||||||||||||||||
Amortization of deferred financing costs | (8) | — | — | 8 | 2 | 6 | — | |||||||||||||||||||||||
Amortization of fair value debt adjustment | (18) | — | — | 18 | 4 | 14 | 0.01 | |||||||||||||||||||||||
Stock compensation | — | — | — | 21 | 4 | 17 | 0.01 | |||||||||||||||||||||||
Restructuring and integration costs | — | — | 143 | 34 | 109 | 0.08 | ||||||||||||||||||||||||
Productivity | — | — | — | 103 | 27 | 76 | 0.05 | |||||||||||||||||||||||
Loss on early extinguishment of debt | — | (4) | — | 4 | 1 | 3 | — | |||||||||||||||||||||||
Impairment of investment and note receivable | — | — | (102) | 102 | 25 | 77 | 0.05 | |||||||||||||||||||||||
Nonroutine legal matters | — | — | — | 43 | 10 | 33 | 0.02 | |||||||||||||||||||||||
COVID-19 | — | — | — | 117 | 29 | 88 | 0.06 | |||||||||||||||||||||||
Adjusted | $ | 404 | $ | — | $ | — | $ | 1,908 | $ | 474 | 24.8 | % | $ | 1,434 | $ | 1.01 | ||||||||||||||
Diluted earnings per common share may not foot due to rounding. |
KEURIG DR PEPPER INC. RECONCILIATION OF SEGMENT ITEMS TO CERTAIN NON-GAAP ADJUSTED SEGMENT ITEMS (Unaudited) | |||||||||||
(in millions) | Reported | Items Affecting Comparability | Adjusted GAAP | ||||||||
For the Third Quarter of 2021 | |||||||||||
Income from Operations | |||||||||||
Coffee Systems | $ | 334 | $ | 43 | $ | 377 | |||||
Packaged Beverages | 288 | 24 | 312 | ||||||||
Beverage Concentrates | 286 | 3 | 289 | ||||||||
Latin America Beverages | 37 | — | 37 | ||||||||
Unallocated corporate costs | (150) | 66 | (84) | ||||||||
Total income from operations | $ | 795 | $ | 136 | $ | 931 | |||||
For the Third Quarter of 2020 | |||||||||||
Income from Operations | |||||||||||
Coffee Systems | $ | 320 | $ | 53 | $ | 373 | |||||
Packaged Beverages | 260 | 44 | 304 | ||||||||
Beverage Concentrates | 262 | 3 | 265 | ||||||||
Latin America Beverages | 25 | — | 25 | ||||||||
Unallocated corporate costs | (114) | 21 | (93) | ||||||||
Total income from operations | $ | 753 | $ | 121 | $ | 874 |
KEURIG DR PEPPER INC. RECONCILIATION OF SEGMENT ITEMS TO CERTAIN NON-GAAP ADJUSTED SEGMENT ITEMS (Unaudited) | |||||||||||
(in millions) | Reported | Items Affecting Comparability | Adjusted GAAP | ||||||||
For the first nine months of 2021: | |||||||||||
Income from Operations | |||||||||||
Coffee Systems | $ | 992 | $ | 145 | $ | 1,137 | |||||
Packaged Beverages | 721 | 74 | 795 | ||||||||
Beverage Concentrates | 778 | 6 | 784 | ||||||||
Latin America Beverages | 95 | 2 | 97 | ||||||||
Unallocated corporate costs | (417) | 115 | (302) | ||||||||
Total income from operations | $ | 2,169 | $ | 342 | $ | 2,511 | |||||
For the first nine months of 2020: | |||||||||||
Income from Operations | |||||||||||
Coffee Systems | $ | 882 | $ | 201 | $ | 1,083 | |||||
Packaged Beverages | 657 | 119 | 776 | ||||||||
Beverage Concentrates | 679 | 5 | 684 | ||||||||
Latin America Beverages | 73 | 2 | 75 | ||||||||
Unallocated corporate costs | (511) | 226 | (285) | ||||||||
Total income from operations | $ | 1,780 | $ | 553 | $ | 2,333 |
KEURIG DR PEPPER INC. RECONCILIATION OF ADJUSTED EBITDA AND MANAGEMENT LEVERAGE RATIO (Unaudited) | |||
(in millions, except for ratio) | |||
ADJUSTED EBITDA RECONCILIATION - LAST TWELVE MONTHS | |||
Net income attributable to KDP | $ | 1,731 | |
Interest expense | 527 | ||
Provision for income taxes | 517 | ||
Loss on early extinguishment of debt | 105 | ||
Impairment of intangible assets | 67 | ||
Other (income) expense, net | (10) | ||
Depreciation expense | 394 | ||
Other amortization | 158 | ||
Amortization of intangibles | 134 | ||
EBITDA | $ | 3,623 | |
Items affecting comparability: | |||
Restructuring and integration expenses | $ | 201 | |
Productivity | 120 | ||
Nonroutine legal matters | 37 | ||
Stock compensation | 20 | ||
COVID-19 | 42 | ||
Transaction costs | 1 | ||
Malware incident | (3) | ||
Mark to market | (139) | ||
Adjusted EBITDA | $ | 3,902 | |
September 30, | |||
2021 | |||
Principal amounts of: | |||
Commercial paper notes | $ | 998 | |
Senior unsecured notes | 11,875 | ||
Total principal amounts | 12,873 | ||
Less: Cash and cash equivalents | 200 | ||
Total principal amounts less cash and cash equivalents | $ | 12,673 | |
September 30, 2021 Management Leverage Ratio | 3.2 |
KEURIG DR PEPPER INC. RECONCILIATION OF ADJUSTED EBITDA - LAST TWELVE MONTHS (Unaudited) | |||||||||||
(in millions) | FOURTH QUARTER OF 2020 | FIRST NINE MONTHS OF 2021 | LAST TWELVE MONTHS | ||||||||
Net income attributable to KDP | $ | 428 | $ | 1,303 | $ | 1,731 | |||||
Interest expense | 146 | 381 | 527 | ||||||||
Provision for income taxes | 130 | 387 | 517 | ||||||||
Loss on early extinguishment of debt | — | 105 | 105 | ||||||||
Impairment of intangible assets | 67 | — | 67 | ||||||||
Other (income) expense, net | (4) | (6) | (10) | ||||||||
Depreciation expense | 90 | 304 | 394 | ||||||||
Other amortization | 40 | 118 | 158 | ||||||||
Amortization of intangibles | 33 | 101 | 134 | ||||||||
EBITDA | $ | 930 | $ | 2,693 | $ | 3,623 | |||||
Items affecting comparability: | |||||||||||
Restructuring and integration expenses | $ | 56 | $ | 145 | 201 | ||||||
Productivity | 22 | 98 | 120 | ||||||||
Nonroutine legal matters | 14 | 23 | 37 | ||||||||
Stock compensation | 6 | 14 | 20 | ||||||||
COVID-19 | 11 | 31 | 42 | ||||||||
Transaction costs | — | 1 | 1 | ||||||||
Malware incident | — | (3) | (3) | ||||||||
Mark to market | (54) | (85) | (139) | ||||||||
Adjusted EBITDA | $ | 985 | $ | 2,917 | $ | 3,902 |
KEURIG DR PEPPER INC.
RECONCILIATION OF NET CASH PROVIDED BY OPERATING ACTIVITIES TO FREE CASH FLOW
(Unaudited)
Free cash flow is defined as net cash provided by operating activities adjusted for purchases of property, plant and equipment, proceeds from sales of property, plant and equipment, and certain items excluded for comparison to prior year periods. For the first nine months of 2021 and 2020, there were no certain items excluded for comparison to prior year periods.
First Nine Months | ||||||||
(in millions) | 2021 | 2020 | ||||||
Net cash provided by operating activities | $ | 1,933 | $ | 1,666 | ||||
Purchases of property, plant and equipment | (325) | (356) | ||||||
Proceeds from sales of property, plant and equipment | 18 | 203 | ||||||
Free Cash Flow | $ | 1,626 | $ | 1,513 |
RECONCILIATION OF CERTAIN CURRENCY NEUTRAL ADJUSTED FINANCIAL RESULTS
(Unaudited)
Net sales, adjusted income from operations and adjusted earnings per share, as adjusted to currency neutral: These adjusted financial results are calculated on a currency neutral basis by converting our current-period local currency financial results using the prior-period foreign currency exchange rates.
Coffee Systems | Packaged Beverages | Beverage Concentrates | Latin America Beverages | Total | |||||||||||
For the third quarter of 2021: | |||||||||||||||
Net sales | 5.3 | % | 6.9 | % | 11.4 | % | 25.8 | % | 7.6 | % | |||||
Impact of foreign currency | (0.7) | % | (0.1) | % | (0.6) | % | (11.3) | % | (0.8) | % | |||||
Net sales, as adjusted to currency neutral | 4.6 | % | 6.8 | % | 10.8 | % | 14.5 | % | 6.8 | % | |||||
For the first nine months of 2021: | |||||||||||||||
Net sales | 9.2 | % | 7.3 | % | 13.2 | % | 23.8 | % | 9.4 | % | |||||
Impact of foreign currency | (1.0) | % | (0.2) | % | (0.5) | % | (9.1) | % | (1.0) | % | |||||
Net sales, as adjusted to currency neutral | 8.2 | % | 7.1 | % | 12.7 | % | 14.7 | % | 8.4 | % | |||||
Coffee Systems | Packaged Beverages | Beverage Concentrates | Latin America Beverages | Total | |||||||||||
For the third quarter of 2021: | |||||||||||||||
Adjusted income from operations | 1.1 | % | 2.6 | % | 9.1 | % | 48.0 | % | 6.5 | % | |||||
Impact of foreign currency | (0.6) | % | (0.3) | % | (0.4) | % | (12.0) | % | (0.8) | % | |||||
Adjusted income from operations, as adjusted to currency neutral | 0.5 | % | 2.3 | % | 8.7 | % | 36.0 | % | 5.7 | % | |||||
For the first nine months of 2021: | |||||||||||||||
Adjusted income from operations | 5.0 | % | 2.4 | % | 14.6 | % | 29.3 | % | 7.6 | % | |||||
Impact of foreign currency | (0.7) | % | (0.2) | % | (0.6) | % | (9.3) | % | (0.8) | % | |||||
Adjusted income from operations, as adjusted to currency neutral | 4.3 | % | 2.2 | % | 14.0 | % | 20.0 | % | 6.8 | % |
Third Quarter of 2021 | First Nine Months of 2021 | |||||||
Adjusted diluted earnings per share | $ | 0.44 | $ | 1.15 | ||||
Impact of foreign currency | — | (0.01) | ||||||
Adjusted diluted earnings per share, as adjusted to currency neutral | $ | 0.44 | $ | 1.14 |
The following table sets forth our reconciliation of significant COVID-19-related expenses. However, employee compensation expense and employee protection costs, which impact our SG&A expenses and cost of sales, are included as the COVID-19 item affecting comparability and are excluded in our Adjusted financial measures. In addition, reported amounts under U.S. GAAP also include additional costs, not included as the COVID-19 item affecting comparability, as presented in tables below.
Items Affecting Comparability(1) | |||||||||||||||||||
(in millions) | Employee Compensation Expense(2) | Employee Protection Costs(3) | Allowances for Expected Credit Losses(4) | Inventory Write-Downs(5) | Total | ||||||||||||||
For the third quarter of 2021: | |||||||||||||||||||
Coffee Systems | $ | 1 | $ | 1 | $ | — | $ | — | $ | 2 | |||||||||
Packaged Beverages | 1 | 1 | — | — | 2 | ||||||||||||||
Beverage Concentrates | — | — | — | — | — | ||||||||||||||
Latin America Beverages | — | — | — | — | — | ||||||||||||||
Total | $ | 2 | $ | 2 | $ | — | $ | — | $ | 4 | |||||||||
For the third quarter of 2020: | |||||||||||||||||||
Coffee Systems | $ | 7 | $ | 5 | $ | — | $ | — | $ | 12 | |||||||||
Packaged Beverages | 32 | 4 | — | — | 36 | ||||||||||||||
Beverage Concentrates | — | — | — | — | — | ||||||||||||||
Latin America Beverages | — | 1 | — | — | 1 | ||||||||||||||
Total | $ | 39 | $ | 10 | $ | — | $ | — | $ | 49 | |||||||||
For the first nine months of 2021: | |||||||||||||||||||
Coffee Systems | $ | 3 | $ | 14 | $ | (2) | $ | — | $ | 15 | |||||||||
Packaged Beverages | 7 | 6 | (8) | — | 5 | ||||||||||||||
Beverage Concentrates | — | — | (3) | — | (3) | ||||||||||||||
Latin America Beverages | — | 1 | — | — | 1 | ||||||||||||||
Total | $ | 10 | $ | 21 | $ | (13) | $ | — | $ | 18 | |||||||||
For the first nine months of 2020: | |||||||||||||||||||
Coffee Systems | $ | 14 | $ | 7 | $ | 2 | $ | 8 | $ | 31 | |||||||||
Packaged Beverages | 73 | 22 | 8 | — | 103 | ||||||||||||||
Beverage Concentrates | — | — | 4 | — | 4 | ||||||||||||||
Latin America Beverages | — | 1 | — | — | 1 | ||||||||||||||
Total | $ | 87 | $ | 30 | $ | 14 | $ | 8 | $ | 139 | |||||||||
(1) | Employee compensation expense and employee protection costs are both included as the COVID-19 items affecting comparability in the reconciliation of our Adjusted Non-GAAP financial measures. |
(2) | In 2021, reflected pay for temporary employees, including the associated taxes, as well as incremental benefits provided to frontline workers such as extended sick leave, in order to maintain essential operations during the COVID-19 pandemic. In 2020, primarily reflected temporary incremental frontline incentive pay and benefits, as well as pay for temporary employees, including the associated taxes. Impacts both cost of sales and SG&A expenses. |
(3) | Included costs associated with personal protective equipment, temperature scans, cleaning and other sanitization services. Impacts both cost of sales and SG&A expenses. |
(4) | In 2020, allowances reflected the expected impact of the economic uncertainty caused by COVID-19, leveraging estimates of credit worthiness, default and recovery rates for certain of our customers. In 2021, reversals of those allowances reflect improving economic conditions. Impacts SG&A expenses. |
(5) | Impacts cost of sales. |
RECONCILIATION OF CERTAIN ADJUSTED FINANCIAL RESULTS
FOR THE FIRST NINE MONTHS OF 2019
(Unaudited, in millions, except per share data)
For the purposes of additional analysis, we have also included certain non-GAAP financial measures for the first nine months of 2019.
For the first nine months of 2019, we define our Adjusted non-GAAP financial measures as certain financial statement captions and metrics adjusted for certain items affecting comparability. The items affecting comparability are defined below.
Adjusted: Defined as certain financial statement captions and metrics adjusted for certain items affecting comparability.
Items affecting comparability: Defined as certain items that are excluded for comparison to prior year periods, adjusted for the tax impact as applicable. Tax impact is determined based upon an approximate rate for each item. For each period, management adjusts for (i) the unrealized mark-to-market impact of derivative instruments not designated as hedges in accordance with U.S. GAAP and do not have an offsetting risk reflected within the financial results; (ii) the amortization associated with definite-lived intangible assets; (iii) the amortization of the deferred financing costs associated with the DPS Merger; (iv) the amortization of the fair value adjustment of the senior unsecured notes obtained as a result of the DPS Merger; (v) stock compensation expense and the associated windfall tax benefit attributable to the matching awards made to employees who made an initial investment in KDP; (vi) non-cash changes in deferred tax liabilities related to goodwill and other intangible assets as a result of tax rate or apportionment changes; and (vii) other certain items that are excluded for comparison purposes to prior year periods.
For the first nine months of 2019, the other certain items excluded for comparison purposes include (i) restructuring and integration expenses related to significant business combinations; (ii) productivity expenses; (iii) transaction costs not associated with the DPS Merger; (iv) costs related to significant non-routine legal matters; (v) the impact of the step-up of acquired inventory not associated with the DPS Merger (vi) the loss on early extinguishment of debt related to the redemption of debt; and (vii) the loss related to the February 2019 organized malware attack on our business operation networks in the Coffee Systems segment.
Net Sales | Income from operations | Diluted earnings per share | ||||||||||
Reported | $ | 8,186 | $ | 1,665 | $ | 0.60 | ||||||
Items Affecting Comparability: | ||||||||||||
Mark to market | — | 1 | 0.02 | |||||||||
Amortization of intangibles | — | 94 | 0.05 | |||||||||
Amortization of deferred financing costs | — | — | 0.01 | |||||||||
Amortization of fair value debt adjustment | — | — | 0.01 | |||||||||
Stock compensation | — | 18 | 0.01 | |||||||||
Restructuring and integration costs | — | 176 | 0.10 | |||||||||
Productivity | — | 77 | 0.04 | |||||||||
Transaction costs | — | 8 | 0.01 | |||||||||
Inventory step-up | — | 3 | — | |||||||||
Loss on early extinguishment of debt | — | — | — | |||||||||
Nonroutine legal matters | — | 27 | 0.01 | |||||||||
Malware incident | — | 8 | — | |||||||||
Adjusted | $ | 8,186 | $ | 2,077 | $ | 0.87 | ||||||
Diluted earnings per common share may not foot due to rounding. |
RECONCILIATION OF CURRENCY NEUTRAL FINANCIAL RESULTS
FOR THE FIRST NINE MONTHS OF 2021 COMPARED TO THE FIRST NINE MONTHS OF 2019
(Unaudited)
Net sales as adjusted to currency neutral: This adjusted financial result is calculated on a currency neutral basis by converting our local currency net sales for the first nine months of 2021 using the foreign currency exchange rates from the first nine months of 2019.
Growth (%) | |||
Net sales growth compared to the first nine months of 2019 | 13.5 | % | |
Impact of foreign currency | (0.2) | % | |
Net sales growth compared to the first nine months of 2019, as adjusted to currency neutral | 13.3 | % |
View original content to download multimedia:https://www.prnewswire.com/news-releases/keurig-dr-pepper-reports-strong-q3-2021-results-and-raises-net-sales-guidance-for-the-year-301410454.html
SOURCE Keurig Dr Pepper Inc.
FAQ
What are Keurig Dr Pepper's financial results for Q3 2021?
What is Keurig Dr Pepper's sales growth outlook for 2021?
How did Keurig Dr Pepper perform in the Beverage Concentrates segment?
What challenges did Keurig Dr Pepper face in Q3 2021?